Publications by authors named "Fabio Corra"

Claim this Profile
I
Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines.
Anna Terrazzan, Francesca Crudele, Fabio Corrà, Pietro Ancona, Jeffrey Palatini

Noncoding RNA· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer.
Gianluca Aguiari, Francesca Crudele, Cristian Taccioli, Linda Minotti, Fabio Corrà

Int J Biol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines.
Fabio Corrà, Francesca Crudele, Federica Baldassari, Nicoletta Bianchi, Marco Galasso

Genes (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA.
Ornella Franzese, Linda Minotti, Gianluca Aguiari, Fabio Corrà, Carlo Cervellati

Amino Acids· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset.
Chiara Agnoletto, Fabio Corrà, Linda Minotti, Federica Baldassari, Francesca Crudele

Cancers (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies?
Linda Minotti, Chiara Agnoletto, Federica Baldassari, Fabio Corrà, Stefano Volinia

High Throughput· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts.
Chiara Agnoletto, Linda Minotti, Laura Brulle-Soumare, Lorenzo Pasquali, Marco Galasso

Biomark Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Network of Non-coding RNAs in Cancer Drug Resistance.
Fabio Corrà, Chiara Agnoletto, Linda Minotti, Federica Baldassari, Stefano Volinia

Front Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.
Federica Baldassari, Carlotta Zerbinati, Marco Galasso, Fabio Corrà, Linda Minotti

Front Genet· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of miR-204 expression is a key event in melanoma.
Marco Galasso, Carl Morrison, Linda Minotti, Fabio Corrà, Carlotta Zerbinati

Mol Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study.
Marco Galasso, Giorgio Costantino, Lorenzo Pasquali, Linda Minotti, Federica Baldassari

Int J Genomics· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pluripotent stem cell miRNAs and metastasis in invasive breast cancer.
Stefano Volinia, Gerard Nuovo, Alessandra Drusco, Stefan Costinean, Ramzey Abujarour

J Natl Cancer Inst· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma.
Farzaneh Moshiri, Elisa Callegari, Lucilla D'Abundo, Fabio Corrà, Laura Lupini

Gastroenterol Hepatol Bed Bench· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
Manuela Ferracin, Cristian Bassi, Massimo Pedriali, Sara Pagotto, Lucilla D'Abundo

Mol Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25.
Saverio Marchi, Laura Lupini, Simone Patergnani, Alessandro Rimessi, Sonia Missiroli

Curr Biol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
Elisa Callegari, Bahaeldin K Elamin, Ferdinando Giannone, Maddalena Milazzo, Giuseppe Altavilla

Hepatology· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis